{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&max-ddpModified.=2015-02-08T03%3A53%3A44.073Z&max-questionFirstMinisteriallyCorrected.=2018-11-21T11%3A59%3A57.143Z&max-answer.questionFirstAnswered.=2019-06-19T13%3A58%3A43.847Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptId=17&max-ddpModified.=2015-02-08T03%3A53%3A44.073Z&max-questionFirstMinisteriallyCorrected.=2018-11-21T11%3A59%3A57.143Z&max-answer.questionFirstAnswered.=2019-06-19T13%3A58%3A43.847Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&max-ddpModified.=2015-02-08T03%3A53%3A44.073Z&max-questionFirstMinisteriallyCorrected.=2018-11-21T11%3A59%3A57.143Z&_metadata=all&max-answer.questionFirstAnswered.=2019-06-19T13%3A58%3A43.847Z", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answeringDeptId=17&max-ddpModified.=2015-02-08T03%3A53%3A44.073Z&max-questionFirstMinisteriallyCorrected.=2018-11-21T11%3A59%3A57.143Z&max-answer.questionFirstAnswered.=2019-06-19T13%3A58%3A43.847Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&max-ddpModified.=2015-02-08T03%3A53%3A44.073Z&max-questionFirstMinisteriallyCorrected.=2018-11-21T11%3A59%3A57.143Z&max-answer.questionFirstAnswered.=2019-06-19T13%3A58%3A43.847Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&max-ddpModified.=2015-02-08T03%3A53%3A44.073Z&max-questionFirstMinisteriallyCorrected.=2018-11-21T11%3A59%3A57.143Z&max-answer.questionFirstAnswered.=2019-06-19T13%3A58%3A43.847Z", "items" : [{"_about" : "http://data.parliament.uk/resources/164499", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/164499/answer", "answerText" : {"_value" : "<p>As at 31 March 2014, the National Health Service Litigation Authority (NHS LA) estimates that it has potential liabilities of £26.1 billion, of which £25.7 billion relates to clinical negligence. This is an increase of £3.1 billion from 31 March 201<del class=\"ministerial\">4<ins class=\"ministerial\">3<\/ins><\/del>, which can mainly be attributed to a continual rise in clinical negligence claims over recent years. There are a number of factors driving this increase, including the rise in the number of patients cared for and in the complexity of their care; and the general rise in litigation across a number of sectors including the NHS, driven in part by \u2018no win, no fee\u2019 agreements. It is anticipated that the effect of the latter is likely to diminish as a result of the Government\u2019s Legal Aid Sentencing and Punishment of Offenders Act of 2012.<\/p><p> <\/p><p>The Department believes the best way to reduce negligence claims is to improve patient care and safety. In March 2014, the Secretary of State for Health issued a call to action to make the NHS the safest healthcare system in the world and achieve a three-year goal to halve avoidable harm and save 6,000 lives. The Sign up to Safety campaign embodies the ambition of the NHS to build a culture of safety, bringing together individuals and organisations with a contribution to make towards the patient safety goal. Elements of this campaign will focus on a reduction in avoidable harm that can lead to compensation claims. Organisations that sign up are setting out what they will do to strengthen patient safety, including a safety improvement plan which shows how their organisation intends to save lives and reduce harm for patients over the next three years. The NHS Litigation Authority, which already provides a \u201csafety and learning service\u201d to trusts<strong>,<\/strong> will support those organisations which have patient safety improvement plans that show a likely reduction in their higher volume, higher value claims.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"}
        }
        , "answeringMemberPrinted" : {"_value" : "Earl Howe"}
        , "dateOfAnswer" : {"_value" : "2014-12-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/164499/answer/previousversion/31769", "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"}
          }
          , "answeringMemberPrinted" : {"_value" : "Earl Howe"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-12-04T16:04:05.87Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-01-13T14:37:59.487Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-11-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Negligence"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government by how much the provision for clinical negligence claims against the National Health Service has grown in the last year; why it has grown; and what strategy is in place for reducing that amount.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4196", "label" : {"_value" : "Biography information for Lord Sharkey"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Sharkey"}
      ], "uin" : "HL3092"}
    , {"_about" : "http://data.parliament.uk/resources/100721", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100721/answer", "answerText" : {"_value" : "<p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p><p> <\/p><p> <\/p><p> <\/p><p><em>£ million<\/em><\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>2009-10<\/p><\/td><td><p>2010-11<\/p><\/td><td><p>2011-12<\/p><\/td><td><p>2012-13<\/p><\/td><td><p>2013-14<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Asthma<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p><del class=\"ministerial\">22.2 <\/del><ins class=\"ministerial\">6.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.5 <\/del><ins class=\"ministerial\">5.3<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.2<\/del><ins class=\"ministerial\"> 4.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.4<\/del><ins class=\"ministerial\"> 3.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">18.8<\/del><ins class=\"ministerial\"> 5.4<\/ins><\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.3<\/p><\/td><td><p>1.5<\/p><\/td><td><p>0.8<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>2.6<\/p><\/td><td><p>3.4<\/p><\/td><td><p>2.4<\/p><\/td><td><p>3.4<\/p><\/td><td><p>3.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p><del class=\"ministerial\">24.8<\/del><ins class=\"ministerial\"> 9.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">21.0<\/del><ins class=\"ministerial\"> 8.8<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.9<\/del><ins class=\"ministerial\"> 7.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">24.3 <\/del><ins class=\"ministerial\">8.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">23.4<\/del> <ins class=\"ministerial\">10.0<\/ins><\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Motor Neurone Research<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>7.0<\/p><\/td><td><p>7.5<\/p><\/td><td><p>4.2<\/p><\/td><td><p>4.1<\/p><\/td><td><p>3.6<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.5<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>7.3<\/p><\/td><td><p>7.8<\/p><\/td><td><p>5.0<\/p><\/td><td><p>5.5<\/p><\/td><td><p>5.1<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Osteoporosis<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>6.2<\/p><\/td><td><p>5.4<\/p><\/td><td><p>5.1<\/p><\/td><td><p>4.6<\/p><\/td><td><p>5.9<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.3<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.8<\/p><\/td><td><p>1.3<\/p><\/td><td><p>1.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>6.5<\/p><\/td><td><p>6.1<\/p><\/td><td><p>6.0<\/p><\/td><td><p>6.3<\/p><\/td><td><p>8.7<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100721/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Osteoporosis"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leicester West"}
      , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
      ], "uin" : "211732"}
    , {"_about" : "http://data.parliament.uk/resources/100723", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100723/answer", "answerText" : {"_value" : "<p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p><p> <\/p><p> <\/p><p> <\/p><p><em>£ million<\/em><\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>2009-10<\/p><\/td><td><p>2010-11<\/p><\/td><td><p>2011-12<\/p><\/td><td><p>2012-13<\/p><\/td><td><p>2013-14<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Asthma<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p><del class=\"ministerial\">22.2 <\/del><ins class=\"ministerial\">6.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.5 <\/del><ins class=\"ministerial\">5.3<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.2<\/del><ins class=\"ministerial\"> 4.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.4<\/del><ins class=\"ministerial\"> 3.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">18.8<\/del><ins class=\"ministerial\"> 5.4<\/ins><\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.3<\/p><\/td><td><p>1.5<\/p><\/td><td><p>0.8<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>2.6<\/p><\/td><td><p>3.4<\/p><\/td><td><p>2.4<\/p><\/td><td><p>3.4<\/p><\/td><td><p>3.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p><del class=\"ministerial\">24.8<\/del><ins class=\"ministerial\"> 9.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">21.0<\/del><ins class=\"ministerial\"> 8.8<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.9<\/del><ins class=\"ministerial\"> 7.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">24.3 <\/del><ins class=\"ministerial\">8.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">23.4<\/del> <ins class=\"ministerial\">10.0<\/ins><\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Motor Neurone Research<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>7.0<\/p><\/td><td><p>7.5<\/p><\/td><td><p>4.2<\/p><\/td><td><p>4.1<\/p><\/td><td><p>3.6<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.5<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>7.3<\/p><\/td><td><p>7.8<\/p><\/td><td><p>5.0<\/p><\/td><td><p>5.5<\/p><\/td><td><p>5.1<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Osteoporosis<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>6.2<\/p><\/td><td><p>5.4<\/p><\/td><td><p>5.1<\/p><\/td><td><p>4.6<\/p><\/td><td><p>5.9<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.3<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.8<\/p><\/td><td><p>1.3<\/p><\/td><td><p>1.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>6.5<\/p><\/td><td><p>6.1<\/p><\/td><td><p>6.0<\/p><\/td><td><p>6.3<\/p><\/td><td><p>8.7<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100723/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Motor Neurone Disease: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to prevent or treat symptoms of motore neurone disease in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leicester West"}
      , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
      ], "uin" : "211734"}
    , {"_about" : "http://data.parliament.uk/resources/100728", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100728/answer", "answerText" : {"_value" : "<p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p><p> <\/p><p> <\/p><p> <\/p><p><em>£ million<\/em><\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>2009-10<\/p><\/td><td><p>2010-11<\/p><\/td><td><p>2011-12<\/p><\/td><td><p>2012-13<\/p><\/td><td><p>2013-14<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Asthma<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p><del class=\"ministerial\">22.2 <\/del><ins class=\"ministerial\">6.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.5 <\/del><ins class=\"ministerial\">5.3<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.2<\/del><ins class=\"ministerial\"> 4.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.4<\/del><ins class=\"ministerial\"> 3.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">18.8<\/del><ins class=\"ministerial\"> 5.4<\/ins><\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.3<\/p><\/td><td><p>1.5<\/p><\/td><td><p>0.8<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>2.6<\/p><\/td><td><p>3.4<\/p><\/td><td><p>2.4<\/p><\/td><td><p>3.4<\/p><\/td><td><p>3.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p><del class=\"ministerial\">24.8<\/del><ins class=\"ministerial\"> 9.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">21.0<\/del><ins class=\"ministerial\"> 8.8<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.9<\/del><ins class=\"ministerial\"> 7.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">24.3 <\/del><ins class=\"ministerial\">8.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">23.4<\/del> <ins class=\"ministerial\">10.0<\/ins><\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Motor Neurone Research<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>7.0<\/p><\/td><td><p>7.5<\/p><\/td><td><p>4.2<\/p><\/td><td><p>4.1<\/p><\/td><td><p>3.6<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.5<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>7.3<\/p><\/td><td><p>7.8<\/p><\/td><td><p>5.0<\/p><\/td><td><p>5.5<\/p><\/td><td><p>5.1<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Osteoporosis<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>6.2<\/p><\/td><td><p>5.4<\/p><\/td><td><p>5.1<\/p><\/td><td><p>4.6<\/p><\/td><td><p>5.9<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.3<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.8<\/p><\/td><td><p>1.3<\/p><\/td><td><p>1.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>6.5<\/p><\/td><td><p>6.1<\/p><\/td><td><p>6.0<\/p><\/td><td><p>6.3<\/p><\/td><td><p>8.7<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100728/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Motor Neurone Disease"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leicester West"}
      , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
      ], "uin" : "211730"}
    , {"_about" : "http://data.parliament.uk/resources/100730", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100730/answer", "answerText" : {"_value" : "<p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p><p> <\/p><p> <\/p><p> <\/p><p><em>£ million<\/em><\/p><p> <\/p><table><tbody><tr><td> <\/td><td><p>2009-10<\/p><\/td><td><p>2010-11<\/p><\/td><td><p>2011-12<\/p><\/td><td><p>2012-13<\/p><\/td><td><p>2013-14<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Asthma<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p><del class=\"ministerial\">22.2 <\/del><ins class=\"ministerial\">6.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.5 <\/del><ins class=\"ministerial\">5.3<\/ins><\/p><\/td><td><p><del class=\"ministerial\">17.2<\/del><ins class=\"ministerial\"> 4.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.4<\/del><ins class=\"ministerial\"> 3.6<\/ins><\/p><\/td><td><p><del class=\"ministerial\">18.8<\/del><ins class=\"ministerial\"> 5.4<\/ins><\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.3<\/p><\/td><td><p>1.5<\/p><\/td><td><p>0.8<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>2.6<\/p><\/td><td><p>3.4<\/p><\/td><td><p>2.4<\/p><\/td><td><p>3.4<\/p><\/td><td><p>3.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p><del class=\"ministerial\">24.8<\/del><ins class=\"ministerial\"> 9.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">21.0<\/del><ins class=\"ministerial\"> 8.8<\/ins><\/p><\/td><td><p><del class=\"ministerial\">19.9<\/del><ins class=\"ministerial\"> 7.2<\/ins><\/p><\/td><td><p><del class=\"ministerial\">24.3 <\/del><ins class=\"ministerial\">8.5<\/ins><\/p><\/td><td><p><del class=\"ministerial\">23.4<\/del> <ins class=\"ministerial\">10.0<\/ins><\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Motor Neurone Research<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>7.0<\/p><\/td><td><p>7.5<\/p><\/td><td><p>4.2<\/p><\/td><td><p>4.1<\/p><\/td><td><p>3.6<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.2<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.5<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>7.3<\/p><\/td><td><p>7.8<\/p><\/td><td><p>5.0<\/p><\/td><td><p>5.5<\/p><\/td><td><p>5.1<\/p><\/td><\/tr><tr><td colspan=\"6\"><p>Osteoporosis<\/p><\/td><\/tr><tr><td><p>Medical Research Council<\/p><\/td><td><p>6.2<\/p><\/td><td><p>5.4<\/p><\/td><td><p>5.1<\/p><\/td><td><p>4.6<\/p><\/td><td><p>5.9<\/p><\/td><\/tr><tr><td><p>Other Research Councils and Innovate UK<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.0<\/p><\/td><td><p>0.1<\/p><\/td><td><p>0.4<\/p><\/td><td><p>1.0<\/p><\/td><\/tr><tr><td><p>National Institute for Health Research<\/p><\/td><td><p>0.3<\/p><\/td><td><p>0.7<\/p><\/td><td><p>0.8<\/p><\/td><td><p>1.3<\/p><\/td><td><p>1.8<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>6.5<\/p><\/td><td><p>6.1<\/p><\/td><td><p>6.0<\/p><\/td><td><p>6.3<\/p><\/td><td><p>8.7<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p> <\/p><p> <\/p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100730/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Osteoporosis: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to treat symptoms of osteoporosis in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leicester West"}
      , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
      ], "uin" : "211735"}
    , {"_about" : "http://data.parliament.uk/resources/100186", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/100186/answer", "answerText" : {"_value" : "<p>Missed or inadequate hydrocortisone administration is not currently included in the list of \u2018never events\u2019.<\/p><p> <\/p><p> <\/p><p> <\/p><p>We can confirm that the current list of Never Events is under review and there is a consultation underway which opened online on the 6 October 2014 and closes on 31 October 2014.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2014-10-28", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100186/answer/previousversion/24770", "answeringMember" : "http://data.parliament.uk/members/3918", "answeringMemberConstituency" : {"_value" : "Battersea"}
          , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-28T15:28:25.797Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-10-28T16:30:53.2329022Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Patients: Safety"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, whether missed or inadequate hydrocortisone administration is included in the NHS list of Never Events.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/95", "label" : {"_value" : "Biography information for Mr Andrew Smith"}
      }
      , "tablingMemberConstituency" : {"_value" : "Oxford East"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Andrew Smith"}
      ], "uin" : "211233"}
    , {"_about" : "http://data.parliament.uk/resources/92843", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/92843/answer", "answerText" : {"_value" : "<p>The Health and Social Care Information Centre General and Personal Medical Services workforce census shows the number of general practitioners (GPs) by age band and gender working in the NHS in England as at 30 September each year.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The attached table shows the number of GPs (excluding registrars and retainers) but including GP providers (partners) and GP others (salaried) by age band and gender as at 30 September 2013 working in the NHS in England.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
        }
        , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
        , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/92843/answer/attachment/1", "fileName" : {"_value" : "PQ210052 GPs by age band.xlsx"}
          , "title" : "GPs by Age Band Sept 2013"}
        , "dateOfAnswer" : {"_value" : "2014-10-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/92843/answer/previousversion/23112", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
          }
          , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
          , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-20T16:41:38.003Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-10-20T16:54:36.8350775Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "General Practitioners"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how many GPs working in the NHS aged (a) 25 to 35, (b) 35 to 45, (c) 45 to 55 and (d) 55 to 65 years old are (i) male and (ii) female.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/534", "label" : {"_value" : "Biography information for Chris Ruane"}
      }
      , "tablingMemberConstituency" : {"_value" : "Vale of Clwyd"}
      , "tablingMemberPrinted" : [{"_value" : "Chris Ruane"}
      ], "uin" : "210052"}
    , {"_about" : "http://data.parliament.uk/resources/92595", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/92595/answer", "answerText" : {"_value" : "<p>Effective sharing of patient information between organisations as part of a person\u2019s direct care has enormous potential to improve patient care, services and treatments and can only be done effectively if patients are given a say over how their personal information is used.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The sharing of patient information, whilst protecting confidentiality, ensures the highest standards of care and clinical safety are consistently met throughout the National Health Service and where standards drop, allowing prompt action to be taken. It also helps to understand what happens to people, especially those with long term conditions, who are cared for away from hospital, and to ensure their needs are met and provides vital information needed to assist and support research into new medicines, and the better treatment of disease.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
        }
        , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
        , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
        , "dateOfAnswer" : {"_value" : "2014-10-17", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/92595/answer/previousversion/22453", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-17T08:53:07.013Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-10-17T09:05:53.0362001Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Records: Databases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the potential benefits to the NHS of increasing the extent to which patient-level data is shared between organisations; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/204", "label" : {"_value" : "Biography information for Paul Burstow"}
      }
      , "tablingMemberConstituency" : {"_value" : "Sutton and Cheam"}
      , "tablingMemberPrinted" : [{"_value" : "Paul Burstow"}
      ], "uin" : "209873"}
    , {"_about" : "http://data.parliament.uk/resources/92598", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/92598/answer", "answerText" : {"_value" : "<p>NHS England made an announcement on the progress of the care.data project on October 7.<\/p><p> <\/p><p> <\/p><p> <\/p><p>Further details can be found at:<\/p><p> <\/p><p> <\/p><p> <\/p><p>http://www.england.nhs.uk/2014/10/07/ccgs-care-data-programme/<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
        }
        , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
        , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
        , "dateOfAnswer" : {"_value" : "2014-10-17", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/92598/answer/previousversion/22454", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
          }
          , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
          , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-17T08:57:51.97Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-10-17T09:05:37.2935139Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-10-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Records: Databases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what recent progress has been made on the care.data project; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/204", "label" : {"_value" : "Biography information for Paul Burstow"}
      }
      , "tablingMemberConstituency" : {"_value" : "Sutton and Cheam"}
      , "tablingMemberPrinted" : [{"_value" : "Paul Burstow"}
      ], "uin" : "209877"}
    , {"_about" : "http://data.parliament.uk/resources/91293", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/91293/answer", "answerText" : {"_value" : "<p>The omission of the figure for financial year 2009-10 (the figure as at September 2009) in the Answer of 5 September 2014, Official Report, column 382W, on general practitioners (GPs), was an error on our part. The September 2010 figures provided instead were accurate and there was no intention to mislead.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The numbers of full-time equivalent (FTE) GPs, excluding retainers and registrars, and including retainers but excluding registrars, working in the NHS in England as at September 2009, 2010 and 2013 are shown in the following table. The number of FTE GPs has increased by 1,051 between 2010 and 2013.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
        }
        , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
        , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/91293/answer/attachment/1", "fileName" : {"_value" : "PQ208788 GP numbers 2009-13.xlsx"}
          , "title" : "GP  Numbers 2009, 2010 and 2013"}
        , "dateOfAnswer" : {"_value" : "2014-10-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/91293/answer/previousversion/21782", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
          }
          , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
          , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-10-14T14:35:00.197Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-10-15T13:58:12.9073906Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2014-09-09", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "General Practitioners"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 5 September 2014, Official Report, column 382W, on General Practitioners, for what reason the figure for financial year 2009-10 (the figure as at September 2009) was not included in that answer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
      }
      , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
      , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
      ], "uin" : "208788"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answeringDeptId=17&max-ddpModified.=2015-02-08T03%3A53%3A44.073Z&max-questionFirstMinisteriallyCorrected.=2018-11-21T11%3A59%3A57.143Z&max-answer.questionFirstAnswered.=2019-06-19T13%3A58%3A43.847Z", "page" : 0, "startIndex" : 1, "totalResults" : 15, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}